Clonal spread of <i>Plasmodium falciparum</i> candidate artemisinin partial resistance <i>Kelch13</i> 622I mutation and co-occurrence with <i>pfhrp2/3</i> deletions in Ethiopia
Abebe A. Fola(John Brown University), Jeffrey A. Bailey(John Brown University), Hiwot Solomon(Federal Ministry of Health), Hassen Mamo(Addis Ababa University), Bokretsion G. Brhane(Ethiopian Public Health Institute), Jonathan B. Parr(University of North Carolina at Chapel Hill), Ashenafi Assefa(University of North Carolina at Chapel Hill), Beyene Petros(Addis Ababa University), Christopher M. Hennelly(University of North Carolina at Chapel Hill), Geremew Tasew(Ethiopian Public Health Institute), Jonathan J. Juliano(University of North Carolina at Chapel Hill), Emily Reichert(Analysis Group (United States)), Hussein Mohammed(Hawassa University), Jane Cunningham(World Health Organization), Rebecca M. Crudal(Brown University), Sindew Mekasha Feleke(Ethiopian Public Health Institute)
Cited by 7
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
Kidney Stone Disease: An Update on Current Concepts
|Advances in Urology|2018|833
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Malaria rapid diagnostic test performance : results of WHO product testing of malaria RDTs : round 5 (2013)
|QUT ePrints (Queensland University of Technology)|2014|254
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190